Lack of MHC class II molecules favors CD8(+) T-cell infiltration into tumors associated with an increased control of tumor growth

por Chaoul, Nada, Tang, Alexandre, Desrues, Belinda, Oberkampf, Marine, Fayolle, Catherine, Ladant, Daniel, Sainz-Perez, Alexander, Leclerc, Claude
Publicado 2017

IL-17 suppresses the therapeutic activity of cancer vaccines through the inhibition of CD8(+) T-cell responses

por Dadaglio, Gilles, Fayolle, Catherine, Oberkampf, Marine, Tang, Alexandre, Rudilla, Francesc, Couillin, Isabelle, Torheim, Eirik A., Rosenbaum, Pierre, Leclerc, Claude
Publicado 2020